全文获取类型
收费全文 | 137531篇 |
免费 | 8538篇 |
国内免费 | 2917篇 |
专业分类
耳鼻咽喉 | 1747篇 |
儿科学 | 3112篇 |
妇产科学 | 4346篇 |
基础医学 | 20501篇 |
口腔科学 | 3817篇 |
临床医学 | 11535篇 |
内科学 | 24899篇 |
皮肤病学 | 2617篇 |
神经病学 | 8901篇 |
特种医学 | 4723篇 |
外国民族医学 | 14篇 |
外科学 | 18726篇 |
综合类 | 8279篇 |
一般理论 | 36篇 |
预防医学 | 9731篇 |
眼科学 | 3371篇 |
药学 | 12165篇 |
15篇 | |
中国医学 | 1768篇 |
肿瘤学 | 8683篇 |
出版年
2022年 | 1234篇 |
2021年 | 1931篇 |
2020年 | 1249篇 |
2019年 | 1690篇 |
2018年 | 2316篇 |
2017年 | 1730篇 |
2016年 | 1792篇 |
2015年 | 2280篇 |
2014年 | 2918篇 |
2013年 | 3293篇 |
2012年 | 4890篇 |
2011年 | 5277篇 |
2010年 | 3129篇 |
2009年 | 2759篇 |
2008年 | 4409篇 |
2007年 | 4601篇 |
2006年 | 4555篇 |
2005年 | 4109篇 |
2004年 | 3608篇 |
2003年 | 3349篇 |
2002年 | 3135篇 |
2001年 | 7150篇 |
2000年 | 7377篇 |
1999年 | 6129篇 |
1998年 | 2158篇 |
1997年 | 1668篇 |
1996年 | 1204篇 |
1995年 | 1120篇 |
1992年 | 3879篇 |
1991年 | 3946篇 |
1990年 | 3663篇 |
1989年 | 3652篇 |
1988年 | 3516篇 |
1987年 | 3353篇 |
1986年 | 3169篇 |
1985年 | 3017篇 |
1984年 | 2071篇 |
1983年 | 1810篇 |
1982年 | 993篇 |
1979年 | 1916篇 |
1978年 | 1191篇 |
1977年 | 989篇 |
1975年 | 1193篇 |
1974年 | 1360篇 |
1973年 | 1413篇 |
1972年 | 1358篇 |
1971年 | 1248篇 |
1970年 | 1138篇 |
1969年 | 1121篇 |
1968年 | 1024篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
M. Simons R. Kimble S. McPhail Z. Tyack 《Burns : journal of the International Society for Burn Injuries》2019,45(8):1792-1809
BackgroundThe measurement of health-related quality of life (HRQoL) provides information about the perceived burden of the health condition and treatments from a lived experience. The Brisbane Burn Scar Impact Profile (caregiver report for young children, BBSIP0–8), developed in 2013, is a proxy-report measure of burn scar-specific HRQoL. The aim of this study was to report its psychometric properties in line with an evaluative purpose.MethodsCaregivers of children up to 8 years of age at risk of burn scarring were recruited into a prospective, longitudinal cohort study. Caregivers completed the BBSIP0–8, Pediatric Quality of Life Inventory and Patient Observer Scar Assessment Scale at baseline (approximately ≥85% of the total body surface area re-epithelialised), 1–2 weeks after baseline and 1-month after baseline. Psychometric properties measured included internal consistency, test–retest reliability, validity and responsiveness.ResultsEighty-six caregivers of mostly male children (55%), of a median age (IQR) of 1 year, 10 months (2 years, 1 month) and total body surface area burn of 1.5% (3.0%) were recruited. Over one third of participants were grafted and 15% had contractures or skin tightness at baseline. Internal consistency of ten item groups ranged from 0.73 to 0.96. Hypothesised correlations of changes in the BBSIP0–8 items with changes in criterion measures supported longitudinal validity (ρ ranging from ?0.73 to 0.68). The majority of item groups had acceptable reproducibility (ICC = 0.65–0.83). The responsiveness of five item groups was supported (AUC = 0.71–0.90).ConclusionThe psychometric properties tested support the use of the BBSIP0–8 as an evaluative measure of burn scar-related health-related quality of life for children aged below eight years in the early post-acute period of rehabilitation. Further investigation at longer time period after burn injury is indicated. 相似文献
5.
6.
目的观察25-羟维生素D3(Vit D3)对2型糖尿病(T2DM)患者早期肾损害的临床疗效。方法纳入T2DM早期肾损伤患者80例,采用随机数字表法等分为治疗组与对照组,对照组继续原有降糖方案,治疗组在既往用药基础上,肌肉注射Vit D3注射液,疗程均为10个月,治疗结束后进行疗效评价。结果 1与治疗前相比,治疗组糖化血红蛋白(HbA1c)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)水平上调,微量白蛋白(MA)、β2-微球蛋白(β2-M)及肾脏损伤分子-1(KIM-1)水平下调,治疗组低于对照组差异有统计学意义(P<0.05)。2与治疗前相比,治疗组治疗后Vit D3水平上调,治疗组高于对照组差异有统计学意义(P<0.01)。3T2DM患者Vit D3水平与MA(r=-0.432),β2-M(r=-0.615),及KIM-1(r=-0.763)水平均呈负相关(P<0.05)。结论 Vit D3可有效减轻T2DM患者的早期肾损害,对肾脏具有保护作用。 相似文献
7.
8.
9.
Yosuke Homma Takashi Shiga Hiraku Funakoshi Dai Miyazaki Atsushi Sakurai Yoshio Tahara Ken Nagao Naohiro Yonemoto Arino Yaguchi Naoto Morimura 《The American journal of emergency medicine》2019,37(2):241-248
Objective
This study assessed the association between the timing of first epinephrine administration (EA) and the neurological outcomes following out-of-hospital cardiac arrests (OHCAs) with both initial shockable and non-shockable rhythms.Methods
This was a post-hoc analysis of a multicenter prospective cohort study (SOS-KANTO 2012), which registered OHCA patients in the Kanto region of Japan from January 2012 to March 2013. We included consecutive adult OHCA patients who received epinephrine. The primary result included 1-month favorable neurological outcomes defined as cerebral performance category (CPC) 1 or 2. Secondary results included 1-month survival and return of spontaneous circulation (ROSC) after arrival at the hospital. Multivariable logistic regression analysis determined the association between delay per minute of the time from call to first EA in both pre- or in-hospital settings and outcomes.Results
Of the 16,452 patients, 9344 were eligible for our analyses. In univariable analysis, the delay in EA was associated with decreased favorable neurological outcomes only when the initial rhythm was a non-shockable rhythm. In multivariable analyses, delay in EA was associated with decreased ROSC (adjusted odds ratio [OR] for one minute delay, 0.97; 95% confidence interval [CI], 0.96–0.98) and 1-month survival (adjusted OR, 0.95; 95% CI, 0.92–0.97) when the initial rhythm was a non-shockable rhythm, whereas during a shockable rhythm, delay in EA was not associated with decreased ROSC and 1-month survival.Conclusions
While assessing the effectiveness of epinephrine for OHCA, we should consider the time-limited effects of epinephrine. Additionally, consideration of early EA based on the pathophysiology is needed. 相似文献10.